Clinical Trial Details
— Status: Completed
Administrative data
| NCT number |
NCT06159530 |
| Other study ID # |
A03021121 |
| Secondary ID |
|
| Status |
Completed |
| Phase |
N/A
|
| First received |
|
| Last updated |
|
| Start date |
January 20, 2022 |
| Est. completion date |
October 10, 2023 |
Study information
| Verified date |
November 2023 |
| Source |
Mansoura University |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Interventional
|
Clinical Trial Summary
This study was performed to compare between the effects of different occlusal materials used
for all on four implant supported mandibular fixed prosthesis with PEEK framework.
Methods of Evaluation
1- Occlusal force analysis using digital occlusal device (occluscan).
The evaluation periods will be done at time of insertion (T0),6 month (T1),12 month(T2) and
18 month(T3) after framework insertion.
Description:
thirty completely edentulous patients will be selected for the study from the outpatient's
clinic of Prosthodontic Department, Faculty of Dentistry, Mansoura University.
The patients will be selected according to the following criteria:
1. lack of satisfaction of mandibular conventional dentures due to denture instability.
2. Atrophy of mandibular ridges with insufficient bone.
3. They were healthy, free from any systemic diseases relating to bone resorption.
4. All patients have sufficient inter-arch space >15 mm.
5. Maxillary and mandibular residual alveolar ridges covered by healthy non-inflamed mucosa
with even compressibility.
6. Normal maxilla-mandibular relationship (class I Angle's classification).
7. All patients will have mandibular bone height not less than 8-10mm as verified by cone
beam CT.
8. Sufficient inter-arch space not less than 23 mm as verified by tentative jaw relation.
And restorative space not less than14 mm as verified by putty index technique.
Exclusion criteria included:
1- Systemic disorders affecting bone (such as uncontrolled diabetes mellitus and
osteoporosis).
2- Local or general contraindication for surgical procedures. 3- History of chemotherapy or
radiation therapy to the head and neck area. 4- Habits as heavy smoking and alcoholism. 5-
Patients with T.M.J disorders or poor neuromuscular co-ordination.
1. For all patient's conventional complete denture will be constructed and adjusted for
insertion and delivery.
2. A cone beam C.T will be done for each patient to determine the bone quality and
quantity.
3. A surgical stent will be designed and fabricated to allow accurate implant placement of
two axially placed anterior implants and two distally tilted posterior implants by about
30 degree to support mandibular overdenture.
4. Surgical placement of implant fixtures on its sites will be done.
5. Multiunit abutments were screwed to the distal implants.
6. The conventional mandibular denture will be modified to act as immediate fixed
prosthesis that replace lost teeth and gingival tissues.
7. After three months, the Polyetheretherketone (PEEK) frame that connects the four
implants will be constructed using digital scan and CAD CAM manufacturing.
8. The milled frame was fixed to the metal caps using DTK cement
9. The BioHPP framework will have prepared abutments projecting from it. After processing,
the framework will be tried in patient mouth for passive fit.
10. Wax interocclusal record was made to establish the occlusal relationship with opposing
teeth.
According to the artificial teeth, the patients will be divided into two groups:
- Group (I): PEEK framework veneered with nanocomposite resin(visio-lign)
- Group (II): PEEK framework veneered with zirconia
11. The inner surface of the artificial teeth will be etched using hydrophosphoric acid then
silane will be used and light cured resin cement will be used for cementation of the
artificial teeth to the PEEK framework
12. The occlusal scheme used with the opposing maxillary denture will be lingualized
balanced occlusion to enhance the stability of mandibular implant overdentures.
Methods of evaluation:
1- Occlusal force analysis using digital occlusal device (occluscan).
The evaluation periods will be done at time of insertion (T0), 6 month (T1), 12 month (T2)
and 18 month (T3) after framework insertion.
